The hematopoietically expressed product of the vav proto-oncogene, Vav
, shares homology with guanine nucleotide releasing factors (GRFs) [al
so called guanosine diphosphate-dissociation stimulators (GDSs)] that
activate Ras-related small guanosine triphosphate (GTP)-binding protei
ns. Human T cell lysates or Vav immunoprecipitates possessed GRF activ
ity that increased after T cell antigen receptor (TCR)-CD3 triggering;
an in vitro-translated Vav fragment that contained the putative GRF d
omain was also active. Vav-associated GRF stimulation after TCR-CD3 li
gation paralleled its tyrosine phosphorylation; both were blocked by a
protein tyrosine kinase (PTK) inhibitor. Vav also was a substrate for
the p56lck PTK. Thus, Vav is a PTK-regulated GRF that may be importan
t in TCR-CD3-initiated signal transduction through the activation of R
as.